ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

NCI To Fund 840 Competing Grants In FY 1991; No Downward Negotiations, But Careful Review

December 7, 1990

Reagan’s Freeze Chills NCI Plan To Hire Outsiders

January 30, 1981

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978

NCI Human Tissue Network Resources Available For Research

January 24, 1997

In Brief: GM Awards Recognize Levine, Levy, Roeder, Tjian; U.S. Science, Tech Medals Awarded

May 14, 1999

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007